
Balchem Corp
BCPC
Updated: 24/09/2026, 10:58:41
Balchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment offers specialty vitamin K2; microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; methylsulfonylmethane; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment distributes ethylene oxide and ammonia primarily for use in the health care industry; and single use canisters for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. It sells its products through sales force, independent distributors, and sales agents. The company was incorporated in 1967 and is headquartered in Montvale, New Jersey.
No summaries found.
- Share price
- $168.24
- Market cap
- $5.41B
- Exchange
- NASDAQ
- Currency
- USD
- CEO
- Theodore L. Harris
- Employees
- 1,379
- IPO date
- 03/06/1986
- Beta
- 0.8110000000000001
- Last dividend
- $0.00
- Day range
- $167.19 – $169.51
- 52-week range
- $139.17 – $183.90
- 1-day performance
- -0.10%
- 1-year performance
- 20.89%
- Current drawdown (1Y)
- -8.52%
- CIK
- 0000009326
- CUSIP
- 057665200
- ISIN
- US0576652004
- Created
- 07/12/2025, 02:57:03
- Last update
- 24/09/2026, 10:58:41
Track Balchem Corp with an AI analyst
See which prediction-market events move BCPC, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.
Free forever to follow AlphaBrain’s AI strategies. No card required.
Balchem Corporation to Participate in the Wells Fargo Industrials Conference on June 10, 2026
GlobeNewsWire • STOCK • 27/05/2026, 09:00:00
Balchem Corporation (BCPC) Q1 2026 Earnings Call Transcript
Seeking Alpha • STOCK • 30/04/2026, 16:31:42
Conestoga Capital SMid Cap Composite Q1 2026 Portfolio Holdings
Seeking Alpha • STOCK • 27/04/2026, 17:29:00
Balchem Corporation Releases 2025 Sustainability Report
GlobeNewsWire • STOCK • 22/04/2026, 09:10:00
Balchem: An Attractive Valuation Makes This Stock A Buy
Seeking Alpha • STOCK • 26/03/2026, 23:27:02
Balchem Corporation (BCPC) Q4 2025 Earnings Call Transcript
Seeking Alpha • STOCK • 20/02/2026, 14:25:02
Balchem Corporation Reports Fourth Quarter and Full Year 2025 Financial Results
GlobeNewsWire • STOCK • 20/02/2026, 08:12:00
Balchem Corporation Announces Quarterly Conference Call for Fourth Quarter and Full Year 2025 Financial Results on February 20, 2026
GlobeNewsWire • STOCK • 06/02/2026, 08:00:00